Antisynthetase syndrome–much more than just a myopathy
AH Opinc, JS Makowska - Seminars in Arthritis and Rheumatism, 2021 - Elsevier
The aim of the study was to summarize current knowledge on antisynthetase syndrome
(ASS), including its epidemiology, pathogenesis, proposed so far diagnostic criteria …
(ASS), including its epidemiology, pathogenesis, proposed so far diagnostic criteria …
Clinical manifestations and treatment of antisynthetase syndrome
JL Marco, BF Collins - Best Practice & Research Clinical Rheumatology, 2020 - Elsevier
Antisynthetase syndrome (ASyS) is an autoimmune disease clinically manifested most often
by interstitial lung disease, myositis, and arthritis. Raynaud's syndrome, fever, and rashes …
by interstitial lung disease, myositis, and arthritis. Raynaud's syndrome, fever, and rashes …
Cutaneous manifestations of dermatomyositis: a comprehensive review
C Mainetti, B Terziroli Beretta-Piccoli… - Clinical reviews in allergy & …, 2017 - Springer
Dermatomyositis (DM) is an idiopathic inflammatory myopathy characterized by the
presence of skin lesions and inflammation of skeletal muscles; however, this feature may be …
presence of skin lesions and inflammation of skeletal muscles; however, this feature may be …
Dermatomyositis clinical and pathological phenotypes associated with myositis-specific autoantibodies
PW Wolstencroft, DF Fiorentino - Current rheumatology reports, 2018 - Springer
Purpose of review Dermatomyositis is an idiopathic inflammatory myopathy with a variety of
systemic and cutaneous manifestations. The myositis-specific autoantibodies (MSAs) are …
systemic and cutaneous manifestations. The myositis-specific autoantibodies (MSAs) are …
Patients with interstitial lung disease secondary to autoimmune diseases: how to recognize them?
D Sambataro, G Sambataro, F Pignataro… - Diagnostics, 2020 - mdpi.com
The diagnostic assessment of patients with Interstitial Lung Disease (ILD) can be
challenging due to the large number of possible causes. Moreover, the diagnostic approach …
challenging due to the large number of possible causes. Moreover, the diagnostic approach …
Antisynthetase syndrome: a distinct disease spectrum
K Huang, R Aggarwal - Journal of scleroderma and related …, 2020 - journals.sagepub.com
The discovery of novel autoantibodies related to idiopathic inflammatory myopathies
(collectively referred to as myositis) has not only advanced our understanding of the clinical …
(collectively referred to as myositis) has not only advanced our understanding of the clinical …
Clinical spectrum of anti-Jo-1-associated disease
S Monti, C Montecucco, L Cavagna - Current Opinion in …, 2017 - journals.lww.com
Clinical spectrum of anti-Jo-1-associated disease : Current Opinion in Rheumatology
Clinical spectrum of anti-Jo-1-associated disease : Current Opinion in Rheumatology Log in …
Clinical spectrum of anti-Jo-1-associated disease : Current Opinion in Rheumatology Log in …
[PDF][PDF] Current concepts and advances in dermatomyositis: a dermatological perspective
D Lim, D Fiorentino, V Werth - Clin Exp Rheumatol, 2023 - clinexprheumatol.org
Dermatomyositis (DM) is an autoimmune disorder in which clinically amyopathic DM,
characterised by hallmark cutaneous findings in the absence of clinical weakness …
characterised by hallmark cutaneous findings in the absence of clinical weakness …
Update on dermatomyositis in adults
N Schlecht, C Sunderkötter, S Niehaus… - JDDG: Journal der …, 2020 - Wiley Online Library
Dermatomyositis (DM) in adults has a prevalence of 6–7 per 100,000 population per year.
This dedicated compact overview was prepared due to an increasing incidence as well as …
This dedicated compact overview was prepared due to an increasing incidence as well as …
Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines
A Meyer, CA Scirè, R Talarico, T Alexander… - RMD open, 2019 - rmdopen.bmj.com
Idiopathic inflammatory myopathies (IIMs) encompass a heterogeneous group of rare
autoimmune diseases characterised by muscle weakness and inflammation, but in …
autoimmune diseases characterised by muscle weakness and inflammation, but in …